Save time and get answers to complex questions with AI chat
Guselkumab brand name?Antiox mebendazole price?Mobic injection patent oehringer ingelheim france?Are there specific stretches to avoid while on lipitor?Does lipitor's use influence blood pressure medication type?
See the DrugPatentWatch profile for Opzelura
Yes. In the European Union, Opzelura (ruxolitinib) cream 1.5% is approved for nonsegmental vitiligo in adults and in children aged 12 years and older. It is not approved in the EU for other indications (as of now). If you’d like, I can pull the exact EMA approval date and the full approved indication text, or share notes on safety and common side effects from the EU labeling.
Other Questions About Opzelura :